Chris Bulman’s Edwards Lifesciences EW Stock Holding History

Chris Bulman’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-109	Closed	-$10.1K	–	216
2024 Q2	$10.1K	Buy	+109	New	+$9.65K	0.01%	297

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Chris Bulman's EW Position: Q3 2024 in Review

Chris Bulman sold out of Edwards Lifesciences (EW) in Q3 2024, closing a stake of 109 shares — an estimated $10.1K sold.

Chris Bulman first reported a position in EW in Q2 2024 and held it in 1 quarter. The position peaked at $10.1K in Q2 2024. 1,193 funds tracked by Wall St. Rank hold EW as of Q3 2024.

Chris Bulman reported no remaining Edwards Lifesciences position as of Q3 2024 after selling out during the quarter.
Chris Bulman sold 109 Edwards Lifesciences shares in Q3 2024, an estimated $10.1K.
Chris Bulman first reported a position in Edwards Lifesciences in Q2 2024 and held it in 1 quarter.
Chris Bulman's Edwards Lifesciences position peaked at $10.1K in Q2 2024.
1,193 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2024.

Based on Chris Bulman's 13F filing for Q3 2024, filed 22 Oct 2024.